The tumor infiltrating lymphocytes may behave differently in cancers and myositis, either taking part in the muscle inflammatory infiltrate, or increasing the expression of checkpoint inhibitors in cancer by means of IFNγ [15]. The gene discussed is IFNG; the disease is cancer.